I believe RXMD qualifies for $2 PPS uplist. Their target was said to be $5, but that isn't the requirement. Armen knew what was in process when he said that he isn't interested in an rs of more than 1:100, hopefully less.
Armen only has common shares now. Those shares will have significant value, IMO. He made the deal, he didn't need to make the deal.
Go RXMD!
I'm here to discover news and share opinions with other investors. All of my posts are my opinions and derivatives.